ASA’s Guidelines for NMB Monitoring: A Dissenting View—And a Response

After approximately three years of dealing with COVID-19 recommendations, mandates and treatments based on very poor if any medical evidence, I think many physicians have become skeptical toward dictums that drop down on us from on high. And if we are not, we should be.

The new guidelines for monitoring neuromuscular blockade^1,2 seem to be a solution, and a very costly one at that, in search of a problem. How dare a